SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the promotion of Dr. Vishwa Srivastava to president and the appointment of Gary Lo as chief financial officer. The leadership changes come as the company advances international expansion plans for its SSi Mantra surgical robotic system and works to secure regulatory clearances in key markets.
Srivastava, who previously served as CEO of the company’s Asia Pacific operations, will focus on building its U.S. business and leading global operations. Both executives are based in the United States. Lo brings more than three decades of financial leadership experience across technology companies, including the medical technology sector, with expertise in capital markets, financial planning and strategic growth.
The appointments are significant as SS Innovations navigates the complex regulatory landscape for medical devices. The company is responding to questions from the U.S. Food and Drug Administration (“FDA”) regarding its 510(k) premarket notification while pursuing CE marking certification in the European Union. These clearances are critical for commercializing the SSi Mantra in two of the world’s largest healthcare markets, and having a dedicated president for U.S. operations and a CFO with capital markets experience could help streamline those efforts.
SS Innovations is also finalizing a pipeline of additional health care technologies at its research and development facility in India, with plans to introduce them in the coming months. The SSi Mantra is a modular, multi-arm surgical robotic system with advanced features such as 3 to 5 robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and the ability to superimpose 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative that enables enhanced portability, ergonomic flexibility, and telesurgery capability. The system utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.
For readers and investors, the leadership moves signal that SS Innovations is positioning itself to execute on its vision of making robotic surgery affordable and accessible to a larger segment of the global population. The company’s progress with the FDA and CE marking will be key milestones to watch. More information about SS Innovations is available at ssinnovations.com or LinkedIn, and the latest news and updates relating to SSII are available in the company’s newsroom at https://nnw.fm/SSII. The full press release can be viewed at https://nnw.fm/dX3qc. This news was distributed by NetworkNewsWire, a specialized communications platform focused on financial news and content distribution. NetworkNewsWire is part of the Dynamic Brand Portfolio at IBN, which offers services including InvestorWire for wire solutions and editorial syndication to 5,000+ outlets. For full terms of use and disclaimers applicable to all content provided by NetworkNewsWire, visit https://www.NetworkNewsWire.com/Disclaimer.

